These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 36569270)

  • 21. Biomarkers for early detection of pancreatic cancer - miRNAs as a potential diagnostic and therapeutic tool?
    Tarasiuk A; Mackiewicz T; Małecka-Panas E; Fichna J
    Cancer Biol Ther; 2021 Jun; 22(5-6):347-356. PubMed ID: 34224317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma circulating tumor DNA in pancreatic adenocarcinoma for screening, diagnosis, prognosis, treatment and follow-up: A systematic review.
    Abdallah R; Taly V; Zhao S; Pietrasz D; Bachet JB; Basile D; Mas L; Zaanan A; Laurent-Puig P; Taieb J
    Cancer Treat Rev; 2020 Jul; 87():102028. PubMed ID: 32485509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Updates in Molecular Profiling of Pancreatic Ductal Adenocarcinoma.
    Lee JJ; Yeh JJ
    Surg Clin North Am; 2024 Oct; 104(5):939-950. PubMed ID: 39237169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The State of the Art on Blood MicroRNAs in Pancreatic Ductal Adenocarcinoma.
    Gao Z; Jiang W; Zhang S; Li P
    Anal Cell Pathol (Amst); 2019; 2019():9419072. PubMed ID: 31583198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation.
    Wang K; Wang X; Pan Q; Zhao B
    Mol Cancer; 2023 Oct; 22(1):167. PubMed ID: 37803304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
    Mardin WA; Mees ST
    Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
    Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
    JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumour DNA: a challenging innovation to develop "precision onco-surgery" in pancreatic adenocarcinoma.
    Pietrasz D; Sereni E; Lancelotti F; Pea A; Luchini C; Innamorati G; Salvia R; Bassi C
    Br J Cancer; 2022 Jun; 126(12):1676-1683. PubMed ID: 35197581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis.
    Manoochehri M; Wu Y; Giese NA; Strobel O; Kutschmann S; Haller F; Hoheisel JD; Moskalev EA; Hackert T; Bauer AS
    Mol Oncol; 2020 Jun; 14(6):1252-1267. PubMed ID: 32243066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer.
    Raufi AG; May MS; Hadfield MJ; Seyhan AA; El-Deiry WS
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma.
    Stroese AJ; Ullerich H; Koehler G; Raetzel V; Senninger N; Dhayat SA
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2377-2390. PubMed ID: 30225540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
    Vila-Navarro E; Duran-Sanchon S; Vila-Casadesús M; Moreira L; Ginès À; Cuatrecasas M; Lozano JJ; Bujanda L; Castells A; Gironella M
    Clin Transl Gastroenterol; 2019 Apr; 10(4):e00029. PubMed ID: 31009404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular landscape of pancreatic ductal adenocarcinoma.
    Sivapalan L; Kocher HM; Ross-Adams H; Chelala C
    Pancreatology; 2022 Nov; 22(7):925-936. PubMed ID: 35927150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multianalyte Prognostic Signature Including Circulating Tumor DNA and Circulating Tumor Cells in Patients With Advanced Pancreatic Adenocarcinoma.
    Chapin WJ; Till JE; Hwang WT; Eads JR; Karasic TB; O'Dwyer PJ; Schneider CJ; Teitelbaum UR; Romeo J; Black TA; Christensen TE; Redlinger Tabery C; Anderson A; Slade M; LaRiviere M; Yee SS; Reiss KA; O'Hara MH; Carpenter EL
    JCO Precis Oncol; 2022 Jul; 6():e2200060. PubMed ID: 35939771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Next-Generation Sequencing in Pancreatic Cancer.
    Shen GQ; Aleassa EM; Walsh RM; Morris-Stiff G
    Pancreas; 2019 Jul; 48(6):739-748. PubMed ID: 31206465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miRNA Profiling of Magnetic Nanopore-Isolated Extracellular Vesicles for the Diagnosis of Pancreatic Cancer.
    Ko J; Bhagwat N; Black T; Yee SS; Na YJ; Fisher S; Kim J; Carpenter EL; Stanger BZ; Issadore D
    Cancer Res; 2018 Jul; 78(13):3688-3697. PubMed ID: 29735554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on the management of pancreatic cancer: surgery is not enough.
    Ansari D; Gustafsson A; Andersson R
    World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status of molecular diagnostic approaches using liquid biopsy.
    Takahashi K; Takeda Y; Ono Y; Isomoto H; Mizukami Y
    J Gastroenterol; 2023 Sep; 58(9):834-847. PubMed ID: 37470859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exosome-encapsulated microRNA-4525, microRNA-451a and microRNA-21 in portal vein blood is a high-sensitive liquid biomarker for the selection of high-risk pancreatic ductal adenocarcinoma patients.
    Kawamura S; Iinuma H; Wada K; Takahashi K; Minezaki S; Kainuma M; Shibuya M; Miura F; Sano K
    J Hepatobiliary Pancreat Sci; 2019 Feb; 26(2):63-72. PubMed ID: 30561106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.